Form 4: Trevi Therapeutics Officer Exercises Stock Options

Christopher Galletta, Trevi Therapeutics' Controller, exercised stock options and acquired common stock under a pre-arranged plan.

Summary

• Christopher Galletta, Controller and Principal Accounting Officer of Trevi Therapeutics, Inc. (TRVI), reported a transaction on December 2, 2025.
• Galletta acquired 4,225 shares of common stock at an exercise price of $0.511 per share.
• This transaction was the result of exercising stock options.
• Following the transaction, Galletta beneficially owns 26,095 shares of common stock.
• The reported common stock holdings include 6,870 shares acquired through the company's employee stock purchase plan.
• The exercised options were part of a grant from February 11, 2022, which vested 25% of the shares on February 11, 2023, and the remaining 75% in equal monthly installments thereafter through February 11, 2026.
• After the exercise, Galletta holds 15,775 unexercised stock options.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The exercise of stock options by an officer is generally a neutral to slightly positive signal, indicating the officer is taking advantage of vested equity and increasing direct ownership. The transaction being under a 10b5-1 plan suggests it is a pre-planned event rather than a reaction to immediate news.

Positives

• An officer, Christopher Galletta, increased direct ownership of common stock, potentially signaling confidence in the company's future.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and systematic approach to stock transactions.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased insider ownership could be viewed positively as a sign of management confidence.
• Employees: The mention of the Employee Stock Purchase Plan (ESPP) highlights a benefit available to employees.

Next Steps

• Remaining 15,775 stock options held by Christopher Galletta will continue to vest according to the original schedule until February 11, 2026.
• Christopher Galletta may exercise additional vested stock options before their expiration date of February 10, 2032.

Key Dates

Recommendation

The filing details a routine insider transaction where an officer exercised stock options under a pre-arranged 10b5-1 plan. While increasing insider ownership can be a positive signal, this type of transaction is generally not indicative of significant new information that would warrant a change in investment recommendation. It primarily reflects the officer's compensation structure and long-term equity plan.

Keywords

Trevi Therapeutics, TRVI, Christopher Galletta, Insider Trading, Stock Option Exercise, Form 4, SEC Filing, Equity Acquisition, Employee Stock Purchase Plan, Rule 10b5-1